Legacy Wealth Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32,285
Closed -$731K 350
2024
Q4
$731K Sell
32,285
-612
-2% -$13.3K 0.2% 148
2024
Q3
$701K Sell
32,897
-5,151
-14% -$101K 0.19% 170
2024
Q2
$726K Buy
38,048
+7,739
+26% +$158K 0.2% 134
2024
Q1
$584K Buy
+30,309
New +$601K 0.16% 201
2023
Q3
Sell
-27,132
Closed -$649K 337
2023
Q2
$649K Sell
27,132
-62
-0.2% -$1.42K 0.23% 145
2023
Q1
$578K Buy
+27,194
New +$521K 0.21% 164
2022
Q4
Sell
-63,714
Closed -$895K 338
2022
Q3
$895K Buy
63,714
+9,856
+18% +$186K 0.39% 77
2022
Q2
$1.34M Sell
53,858
-48
-0.1% -$1.43K 0.54% 39
2022
Q1
$1.82M Buy
53,906
+17,014
+46% +$560K 0.65% 26
2021
Q4
$1.2M Buy
36,892
+27,264
+283% +$898K 0.41% 62
2021
Q3
$337K Sell
9,628
-79
-0.8% -$3.09K 0.15% 224
2021
Q2
$404K Buy
9,707
+72
+0.7% +$2.88K 0.18% 210
2021
Q1
$355K Buy
+9,635
New +$364K 0.16% 218

Other funds holding FMS

Legacy Wealth Asset Management's FMS Position: Q1 2025 in Review

Legacy Wealth Asset Management sold out of Fresenius Medical Care (FMS) in Q1 2025, closing a stake of 32,285 shares — an estimated $731K sold.

Legacy Wealth Asset Management first reported a position in FMS in Q1 2021 and held it in 13 quarters. The position peaked at $1.82M in Q1 2022. 201 funds tracked by Wall St. Rank hold FMS as of Q1 2025.

  • Legacy Wealth Asset Management reported no remaining Fresenius Medical Care position as of Q1 2025 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 32,285 Fresenius Medical Care shares in Q1 2025, an estimated $731K.
  • Legacy Wealth Asset Management first reported a position in Fresenius Medical Care in Q1 2021 and held it in 13 quarters.
  • Legacy Wealth Asset Management's Fresenius Medical Care position peaked at $1.82M in Q1 2022.
  • 201 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2025.

Based on Legacy Wealth Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.